E
Acorda Therapeutics, Inc.
OTC PK
Recommendation
Sell
Prev Close
$0.426
Volume
--
Avg Vol (90D)
92,401
Market Cap
$529.13K
Dividend & Yield
--
52-Week Range
$0.25 - $24.20
P/E (TTM)
--
EPS (TTM)
-$203.87
My Lists My Alerts
Report
Rating
Reward
E
Very Weak
Risk
D-
Weak
Rating Factors
Growth Index
Weak
Efficiency Index
Very Weak
Solvency Index
Weak
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$117.63M
EBITDA (TTM)
$8.40M
EBIT (TTM)
-$23.26M
Net Income (TTM)
-$252.85M
Balance Sheet
Total Assets (Q)
$108.53M
Total Debt (Q)
$190.90M
Total Liabilities (Q)
$266.48M
Book Value Per Share (Q)
-$127.17
Cash Flow
Cash from Operations (TTM)
-$13.98M
Cash from Investing (TTM)
-$264.00K
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
-$14.06M
Filings
Filing Date
Monday, April 1, 2024
Period Date
Sunday, December 31, 2023
Next Filing
Week of May 6 and 10 (est)
Price History
Loading...
Beta
0.60
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
--
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Apr 12, 2024 - $0.25
52-week High
May 08, 2023 - $24.20
Valuation
Market Cap
$529.13K - Nano Cap
Enterprise Value
$161.45M
Price/Sales (TTM)
0.00
Price/Book (Q)
0.00
Dividends and Shares
Shares Outstanding
1.24M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.acorda.com
Phone Number
914 347 4300
Address
2 Blue Hill Plaza
Pearl River, NY 10965
Country
United States
Year Founded
1995
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Acorda Therapeutics, Inc., a biopharmaceutical company, develops and commercializes therapies for neurological disorders in the United States. The company markets Ampyra (dalfampridine), an oral... more
Weiss Ratings